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Abstract 
We have investigated the plasma membrane (PMCA) and endoplasmic reticulum (SERCA) CaZ+-ATPases involved in active transport 
of Ca 2+ in pancreatic /3-cell ines (MIN6, HIT TI5, RINm5F) and in islets of Langerhans. Under selective membrane phosphorylation 
conditions (at low ATP concentration, in the presence of Ca 2+ and La 3+ and in the absence of Mg 2+ at 4 ° C) the only labelled proteins 
are the phosphoenzyme i~ttermediates of the Ca2+-ATPases. Under these conditions, /3-cell membranes incorporated 32p from 
[y-32p]ATP into two proteins with molecular mass on acidic SDS-polyacrylamide g ls of around 115 and 150 kDa. The 150 kDa band 
was identified as PMCA (i) by reaction with a monoclonal nti-human erythrocyte plasma membrane Ca2+-ATPase antibody; (ii) by its 
typical tryptic cleavage pattern which generated an 80 kDa band; (iii) by lack of inhibition of its autophosphorylation by SERCA-specific 
inhibitors. The 115 kDa band was identified as SERCA (i) by reaction with a polyclonal anti-rat fast skeletal muscle Ca2+-ATPase 
antibody; (ii) by the concentration-dependent inhibition of its autophosphorylation by thapsigargin and 2,5-di(t-butyl)-l,4-benzohydro- 
quinone (tBHQ), which are specific inhibitors of SERCA. The 115 kDa band was further characterised as the SERCA-2b isoform by 
reaction with a polyclonal rabbit antibody against he 12 C-terminal amino acids of SERCA-2b. 
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1. Introduction 
A rise in intracellular Ca 2+ is the key trigger to insulin 
secretion. Stimulation of the pancreatic /3-cell by an in- 
crease in extracellular glucose concentration causes depo- 
larisation and opening of voltage-sensitive Ca2+-channels; 
the ensuing influx of Ca 2+ ions triggers the exocytotic 
Abbreviations: SERCA, sarco(endo)plasmic reticulum Ca2+-ATPase; 
PMCA, plasma membrane Ca2+-ATPase; SR, skeletal muscle sarco- 
plasmic reticulum; HE, human erythrocyte; RE, rat erythrocyte; IL, islets 
of Langerhans; MIN, M1N6 /3.-cell ine; HIT, HIT T15 /3-cell line; RIN, 
RINm5F/3-cell line; EM-2 and EM-3, rabbit polyclonal anti-rat skeletal 
muscle sarcoplasmic reticulum Ca2+-ATPase antibodies; SERCA-2b anti- 
body, rabbit polyclonal anti-peptide antibody raised against he 12 C- 
terminal amino acids of the SERCA-2b Ca2+-ATPase; 5F10, monoclonal 
anti-human erythrocyte Ca2+-ATPase antibody (Clone 5F10); tBHQ, 2,5 
di(t-butyl)-l,4-benzohydroquinone; PMSF, phenylmethylsulfonyl fluo- 
ride; DTT, dithiothreitol; Mops, (3-[ N-morpholino]propane-sulfonic acid); 
PAGE, polyacrylamide gel electrophoresis; DMSO, dimethyl sulfoxide; 
TCA, trichloroacetic a id. 
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release of insulin. This regulatory effect of glucose on 
insulin secretion involves intracellular metabolism of the 
sugar and changes in the probability of opening of ATP- 
sensiti~e (K-ATP) channels in the /3-cell membrane via an 
increase in the ratio of [ATP]/[ADP] near the plasma 
membrane [1]. Although increased influx of Ca 2+ across 
the plasma membrane represents the main mechanism 
whereby glucose elicits insulin secretion, mobilisation of 
Ca 2÷ from intracellular stores is an important additional 
process in the response of the /3-cell to modulators of 
secretion such as acetylcholine, which activate phospho- 
lipase C and increase the /3-cell content of IP 3 [2]. There is 
also evidence that cyclic ADP ribose may mobilise Ca 2÷ 
from intracellular stores sensitive to this second messenger 
[3]. Following its elevation by insulin secretagogues,/3-cell 
Ca z+ must be rapidly lowered again by extrusion from the 
cell and by uptake into the endoplasmic reticulum against 
steep gradients of Ca 2÷. In eukaryotic ells, these active 
movements of Ca 2÷ ions are carried out by Ca 2+ pumps 
located in the plasma membranes and subcellular Ca 2÷ 
stores [4-7]. 
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The plasma membrane Ca2+-ATPase xists in a number 
of isoforms encoded by a multigene family [4]. Screening 
of diverse mammalian cDNA libraries has indicated the 
presence at least four gene products (PMCA1-4) whose 
cDNA sequences have been determined [8-12]; further 
variability is generated via alternative splicing [13-15]. 
Isoforms 1 and 4 are transcribed in most tissues in approxi- 
mately similar amounts, whereas isoforms 2 and 3 are 
transcribed in appreciable amounts only in specialised 
tissues (muscle and brain), the gene product 1 being the 
more abundantly expressed [15]. The pump has a single 
polypeptide chain of 130-141 kDa [4,16,17]. 
The Ca2+-ATPase of sarco(endo)plasmic reticulum is 
an intrinsic membrane protein which has a single polypep- 
tide chain of 110-115 kDa. Five SERCA isoforms have 
been identified that are derived from three genes - -  
SERCA-1, -2, and -3 [18-20]. Alternative splicing of 
SERCA-1 and -2 generates additional isoform diversity. 
SERCA-la is the major adult fast-twitch skeletal isoform 
and is expressed at high levels in membranes of striated 
muscle SR; SERCA-lb is regulated evelopmentally and 
is expressed exclusively in neonatal fast-twitch muscle 
tissues. The SERCA-2 gene also gives rise to two forms: 
SERCA-2a, found in slow-twitch and cardiac muscle, and 
SERCA-2b, which has a broader tissue distribution than 
other isoforms and is considered the major ER-type Ca 2+ 
pump of non-muscle cells. The SERCA-3 gene encodes a
single transcript which, like SERCA-2b, has a largely 
non-muscle localisation [21]. Cells may express more than 
one SERCA gene product or isoforms of the same type 
[22]. In adrenal chromaffin cells, for example, there is 
evidence that distinct isoforms mediate Ca2+-uptake into 
different intracellular Ca2+-stores [23]. Interestingly, acinar 
pancreas has been shown to contain two species of the 
SERCA-2b type [24]. 
In crude homogenates of rat islets, ATP hydrolysis 
ascribed to the activity of a plasma membrane Ca 2+- 
ATPase has been reported [25-28]. However, in these 
studies, the membrane preparation used would have con- 
tained other Ca2+-ATPases including that of the endoplas- 
mic reticulum and also ectoATPase [29]. Moreover the 
presence of other cell types besides /3-cells further compli- 
cates interpretation f these data. 
Worley et al. [30] observed that the extent of filling of 
endoplasmic reticulum Ca 2+ store regulates the membrane 
potential of islet /3-cells, thereby controlling Ca 2+ influx 
and, consequently, insulin secretion. Roe et al. [31 ] demon- 
strated irect evidence that abnormalities in the pattern of 
glucose-stimulated Ca 2+ signalling are connected with the 
development of non-insulin-dependent diabetes mellitus 
(NIDDM). Thus, in an animal model of NIDDM (the 
db/db  mouse), the defects in the pattern of glucose-in- 
duced changes in the intracellular f ee Ca 2 + concentration 
and insulin secretion coincided with a loss of 
sarco(endo)plasmic reticulum Ca2+-ATPase activity. It has 
also been found that the high glucose level characteristic 
of uncontrolled diabetes probably leads to glycosylation of 
the plasma membrane Ca 2+ pump and its inhibition in 
erythrocyte membranes [7]. Since it has been proposed that 
disorders of intracellular calcium metabolism play an es- 
sential role in the pathophysiology of diabetes and its 
complications and the associated abnormalities in both 
action and secretion of insulin [32], molecular characterisa- 
tion of the /3-cell Ca2+-pumping ATPases is an important 
goal. 
In the present study, the nature of the sarco 
(endo)plasmic reticulum and the plasma membrane Ca 2+- 
ATPases in cultured /3-cells and islets of Langerhans has 
been investigated by autophosphorylation and immuno- 
chemical characterisation. The data demonstrate that 
SERCA-2b and probably the PMCA-1 forms are present. 
2. Materials and methods 
Male Wistar rats (200-250 g) and New Zealand rabbits 
were purchased from Harlan U.K., Bicester, UK. Human 
blood was from National Blood Transfusion Centre (Safety 
Tested, Donor Blood), Oxford, UK. MIN6, HIT T15 and 
RINm5F /3-cells were generously provided by Prof. Y. 
Miyazaki, University of Tokyo, Prof. A.E. Boyd III, Tufts 
University, Boston, and Prof. C.B. Wollheim, University 
of Geneva, respectively. Monoclonal anti-human erythro- 
cyte plasma membrane Ca2+-ATPase antibody (Clone 
5F10) was obtained from Cambridge Bioscience, Cam- 
bridge, UK. Rabbit anti-peptide antibody, raised against 
the 12 C-terminal amino acids of the SERCA-2b Ca 2+- 
ATPase [24], was kindly supplied by Dr R.L. Dormer, 
University of Wales College of Medicine, Cardiff, UK. 
The production and characterisation of rabbit anti-rat 
skeletal muscle sarcoplasmic reticulum Ca2+-ATPase anti- 
bodies (EM-2 and EM-3) was described previously [33- 
37]. Tissue culture materials were purchased from Gibco 
Life Technologies, Paisley, Strathclyde, UK. [3,_32 P]ATP 
(5000 Ci/mmol) was from Amersham, Little Chalfont, 
UK. Trypsin, soybean trypsin inhibitor, collagenase (type 
V), proteinase inhibitors, thapsigargin, goat anti-rabbit IgG 
and goat anti-mouse IgG alkaline phosphatase labelled 
antibodies were from Sigma, Poole, Dorset, UK. 2,5-di(t- 
butyl)-l,4-benzohydroquinone (tBHQ) was from Aldrich, 
Gillingham, Dorset, UK. Molecular weight markers were 
obtained from Pharmacia Biosystems, Milton Keynes, UK. 
All other chemicals were of reagent grade. 
2.1. Cell culture 
MIN6, HIT T15 and RINm5F fl-cells were cultured in 
RPMI 1640 tissue culture medium containing penicillin 
(100 U/ml), streptomycin (0.1 mg/ml) and foetal calf 
serum 10% (v/v)  at 37 ° C in an atmosphere of humidified 
air (95%) and CO 2 (5%) as previously described [38]. 
Cells were passaged weekly and harvested using trypsin- 
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EDTA. They were seeded in culture flasks at a density of 
4. 10 7 cells per flasks and cultured for 6 days before 
membrane preparation. 
2.2. Isolation of islets of l~ngerhans 
Islets were obtained by collagenase digestion of rat 
pancreas [39]. The isolated islets were washed four times 
in Hepes/Krebs buffer (pH 7.4) (119 mM NaC1, 4.75 mM 
KC1, 5 mM NaHCO 3, 2.5 mM CaC12, 1.2 mM MgSO4, 
1.2 mM KH2PO 4, 20 mM Hepes-Na, 1 mM PMSF, 1 mM 
iodoacetamide, 1 mM benzamidine, 2 mM DTT, 1 mM 
EDTA, 0.1 mg/ml soybe.an trypsin inhibitor and 10 /~M 
leupeptin) and selected under a dissecting microscope. 
2.3. Membrane preparation from cultured B-cells 
/xM /3-mercaptoethanol, 20 mM Tris-EDTA (pH 8.5) and 
twice with 10 mM Tris-HC1 (pH 7.4). The final pellet was 
resuspended to a concentration of 4-5 mg/ml membrane 
protein in 5 mM Tris-HCl, 0.16 M KC1 (pH 7.4). 
2.6. Preparation of sarcoplasmic reticulum 
Sarcoplasmic reticulum vesicles were isolated from pre- 
dominantly white skeletal muscles of New Zealand rabbits 
as described by Nakamura et al. [42], and the final pellet 
was resuspended in 0.3 M sucrose, 10 mM Tris-maleate 
(pH 7.0) at protein concentration f 30-40 mg/ml. 
All the membrane preparations were aliquoted, frozen 
immediately in liquid nitrogen and stored at -70  ° C. 
Protein concentrations were determined using BSA as 
standard [43]. 
The membranes from /3-cells were prepared as previ- 
ously described [40]. In brief, after washing twice with 
phosphate-buffered saline (7.2. 106 cell/ml buffer), 
trypsinised cells were re, suspended in hypotonic 5 mM 
Tris-HC1 buffer (pH 8.0) (5 • 107 cell/ml buffer) contain- 
ing proteinase inhibitors (1 mM PMSF, 1 mM iodoacet- 
amide, 1 mM benzamidine, 2 mM DTT, 1 mM EDTA, 0.1 
mg/ml soybean trypsin inhibitor and 10 /xM leupeptin), 
left for 40 min on ice and then homogenised in a glass 
homogeniser. The homogenate was centrifuged at 4 ° C for 
10 min at 900 X g, then the supernatant was further cen- 
trifuged for 40 min at 120000 X g. The pellets were 
resuspended at a concentration of 3-6 mg/ml protein in 
ice-cold 20 mM Mops buffer (pH 7.4) containing the 
proteinase inhibitors described above. 
2.4. Membrane preparation from islets of Langerhans 
The freshly selected islets were washed twice in 
Hepes/Krebs buffer (pH 7.4) containing proteinase in- 
hibitors and homogenised in a glass homogeniser in ice- 
cold 5 mM Tris-hypotonic buffer (pH 8.0) and incubated 
for 1 h at 4 ° C. The homogenate was centrifuged at 900 X g 
for 10 min to remove nuclei and the supernatant cen- 
trifuged at 120 000 X g. The final pellet was resuspended 
in 20 mM Mops buffer (pH 7.4) at a concentration of 
0.5-1 mg protein/ml. 
In preliminary studies, islet membranes were prepared 
by sonication (DAWE Soniprobe, UK) on ice with 75 W 
for 6 X 3 s in Mops buffer (pH 7.4) at a concentration of
0.5-1 mg/ml protein. 
2.5. Preparation of red blood cell membrane uesicles 
2.7. Pretreatment of membranes with trypsin, thapsigargin 
and / or tBHQ 
Trypsin treatment was performed at 4 ° C in 20 /xM 
CaCI 2, 50 /zM LaC13, 75 mM KC1, 30 mM KOH-Hepes 
(pH 7.0) containing 0.5-1.0 mg/ml membrane proteins or 
0.12-0.25 /zg/ml SR membrane fractions and 10-100 
/zg/ml trypsin. The reaction was terminated after 2 or 5 
min by adding a 20-fold excess of soybean trypsin in- 
hibitor. In tBHQ and thapsigargin i hibition experiments, 
the untreated or trypsin pre-treated membrane suspensions 
were incubated for 5 min at 37 ° C with 5 • 10-6-10 -2 M 
tBHQ or  10-7 -5  • 10 -5  M thapsigargin (added as a 50-fold 
concentrated solution in dimethyl sulfoxide), placed on ice 
for an additional 10 min and then the membrane vesicles 
were processed for Ca2+-pump radiolabelling. 
2.8. Phosphorylation of the membrane-bound calcium 
pump proteins 
Phosphorylation was carried out at 4 ° C in the medium 
used for proteolysis. The reaction was started by the 
addition of [y-32p]ATP (0.8 pM final concentration) with 
vigorous tirring. The reaction was stopped after 1 min by 
the addition of ice-cold 12% (w/v) TCA containing 2 mM 
ATP and 20 mM KH2PO4,  and the samples were washed 
twice with the same solution. The final precipitates were 
dissolved in the electrophoresis sample buffer containing 
10 mM EDTA, 60% sucrose, 0.015% Bromophenol blue, 
2% SDS and 0.15 M Tris-HC1 (pH 6.8). The pH of the 
samples were adjusted to 7.5-8.0 using 1.7 M Tris-base 
and incubated for 15 min at room temperature before 
electrophoresis. 
Membrane vesicles from human and rat red blood cells 
were prepared as described by Sarkadi et al. [41]. Briefly, 
red cell ghosts prepared in hypotonic buffer (10 mM 
Tris-HCl, 20 mM KC1, 20 mM sucrose, pH 7.4) were 
washed twice with 40 volumes of 0.5 mM Tris-HC1, 50 
2.9. Acidic SDS-polyacrylamide g l electrophoresis ofpro- 
teins 
Electrophoresis was performed on 1 mm thick acidic 
SDS-polyacrylamide g ls (7.5%) [44]. Membrane samples 
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(50-100 /.Lg membrane protein or 12.5-25 ng SR) were 
run in each well along with molecular mass standards 
(myosin, 212 kDa; az-macroglobulin, 170 kDa; /9-galacto- 
sidase, 116 kDa; phosphorylase b, 94 kDa; transferrin, 76 
kDa; bovine serum albumin, 67 kDa; glutamic dehydro- 
genase, 53 kDa; ovalbumin, 43 kDa; carbonic anhydrase, 
30 kDa; trypsin inhibitor, 20 kDa). The gels were run for 
approx. 3 h with 15 mA constant current (70-120 V) at 
4 ° C on a vertical gel electrophoresis apparatus (AE-6400 
Dual Mini Slab Kit, ATTO, Tokyo, Japan). The slabs were 
either electroblotted onto Immobilon membranes or stained 
for 1 h in 10% (v/v)  acetic acid, 50% (v/v)  methanol and 
0.05% (w/v) Coomassie brilliant blue R-250. Destaining 
was carried out in 10% (v/v)  acetic acid, 37% (v/v) 
methanol, 5% (v/v)  glycerol for 2 h. Autoradiography of 
the stained and dried gels was performed with 24-72 h of 
exposure at - 70 ° C by using x-ray Hyperfilms (Amersham, 
Little Chalfont, UK) and intensifying screens. 
2.10. Electrophoretic transfer for immunoblot analysis of 
membrane samples 
Proteins were transferred electrophoretically onto 
poly(vinylidene difluoride) microporous membrane (Im- 
mobilon; Millipore, Bedford, MA, USA) using an AE-6675 
Horizoblot Electrophoretic Transfer Unit with a discontin- 
uous buffer system for 2 h at room temperature asrecom- 
mended by the manufacturer (ATTO, Tokyo, Japan). 
Molecular mass markers were stained with 0.01% (w/v) 
Coomassie brilliant blue R-250 in 50% (v/v)  methanol 
and 10% (v/v)  acetic acid for 5 min and then destained in 
50% (v/v)  methanol, 10% (v/v)  acetic acid for 5-10 rain. 
3. Results 
3.1. Demonstration f the Ca 2 +-pumps in ~9-cell lines and 
in islets of Langerhans 
To identify the types of Ca2+-pump in cultured /9-cells 
and in islets of Langerhans elective protein phosphoryla- 
tion was used. Under special membrane phosphorylation 
conditions (at low ATP concentration, in the presence of 
Ca 2+ and La 3+ and in the absence of Mg 2+ at 4 ° C) the 
only labelled proteins are the plasma membrane and endo- 
plasmic reticulum or sarcoplasmic reticulum-type calcium 
pumps [44]. Using these conditions, membranes from MIN, 
HIT and RIN /9-cells incorporated 32p from ['y-32p]ATP 
into two proteins forming separate bands on acidic gels 
with molecular mass around 115 and 150 kDa (Fig. 1). 
The phosphorylation pattern of islet of Langerhans i also 
shown in Fig. I. Preliminary experiments using sonicated 
islet membrane preparations resulted in at least five phos- 
phorylated bands appearing with molecular mass about 
150 kDa, 115 kDa, 68 kDa, 55 kDa and 35 kDa (Fig. 1, 
ILl). The lower bands (68, 55 and 35 kDa) are likely to be 
proteolytic fragments of the 150 and 115 kDa proteins. 
Subsequent experiments used membranes prepared by ho- 
mogenisation after prior removal of nuclei. With these 
preparations a large diffuse band appeared on autoradio- 
grams with molecular mass between 110 and 160 kDa 
(Fig. 1. IL2) which did not resolve clearly into two 
separate bands. Human erythrocyte and skeletal muscle 
sarcoplasmic reticulum membranes were used as controls. 
In the erythrocyte membrane the only protein phospho- 
rylated was the 140 kDa calcium pump, while in the 
skeletal muscle sarcoplasmic reticulum membrane the 
2.11. lmmunostaining ofImmobilon membranes 
Before immunostaining, the Immobilon sheets were 
blocked overnight at 4 ° C with 5% (w/v)  non-fat dry milk 
and 1:50 dilution of normal swine serum in PBS (blocking 
solution). The proteins on Immobilon sheets were reacted 
with different SERCA or PMCA specific antibodies (EM-2 
and EM-3 polyclonal antibodies 1:1000, SERCA-2b poly- 
clonal antibody 1:750 and 5F10 monoclonal antibody 
1:1000 diluted in blocking solution for 12-16 h at 4°C. 
After washing twice for 5 min with PBS containing 0.05% 
(v/v)  Tween-20 and once with blocking solution, the 
membrane filters were incubated for 4 h at room tempera- 
ture with alkaline phosphatase conjugated anti-rabbit IgG 
diluted 1:15000 or anti-mouse IgG diluted 1:7500 in 
blocking solution, followed by several rinses with PBS 
containing 0.05% (v/v)  Tween-20 for 20 min. The bound 
antibodies were visualized by addition of substrate solution 
containing 0.46 mM nitrobtue tetrazolium, 0.2 mM 5- 
bromo-4-chloro-3-indolyl-phosphate toluidine salt, 0.1 M 
Tris-base (pH 9.5), 0.1 M NaC1 and 0.05 M MgCI 2. 
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Fig. 1. Detection of the phosphoenzyme intermediates of the Ca 2+- 
ATPases in cultured /3-cells, islets of Langerhans, human erythrocytes 
and sarcoplasmic reticulum. 50 tzg of membrane proteins from MIN, HIT 
and RIN /3-cells, islets of Langerhans (ILl and IL2) and from human 
erythrocytes (HE) and 12.5 ng sarcoplasmic reticulum (SR) were labelled 
with [y-32p]ATP in the presence of 20 /zM Ca 2+ and 50 /xM La 3+ as 
described under Section 2. Phosphorylated membrane proteins were 
separated on 7.5% acidic SDS-polyacrylamide g ls and autoradiographed. 
Membranes from islets of Langerhans were prepared by sonication (ILl) 
or by homogenisation and centrifugation (IL2). The positions of the 
molecular mass standards are indicated on the left. 
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Fig. 2. Immunolabelling of sarco(cndo)plasmic r ticulum Ca2+-ATPasc in cultured [3-cell lines, islets of Langerhans and sarcoplasmic reticulum using 
polyclonal ntibodies for SERCA and SERCA-2b. Membrane samples prepared from MIN, HIT and RIN /3-cell lines, islets of Langerhans ([L) and 
sarcoplasmic reticulum (SR) were immunolabelled with rabbit anti-rat skeletal muscle SR CaZ+-ATPase antibodies: EM-2 (lanes A), EM-3 (lanes B) and a 
rabbit anti-peptide antibody, raised against the 12 C-terminal mino acids of the SERCA-2b Ca2+-ATPase: SERCA-2b (lanes C). 25 ng of SR and 100 ,u.g 
of membrane proteins were applied to each lane of 7.5% acidic SDS-polyacrylamide gels and then transferred onto Immobilon membranes. For 
immunoblot analysis, EM-2, EM-3 antibodies at 1:1000 and SERCA-2b antibody at 1:750 dilutions were used. The bound antibodies were visualised by 
alkaline phosphatase-conjugated an i-rabbit IgG (1 : 15 000 dilution). 
phosphorylated protein was the 105 kDa calcium pump 
(Fig. 1, HE and SR). 
3.2. Immunological detection of SERCA and PMCA in 
E-cell lines and in islets of Langerhans 
The EM-2 and EM-3 ~mtibodies, which recognise all the 
known isoforms of SERCA [33-37], reacted with a 115 
kDa protein in all samples from cultured /3-cells and from 
islets of Langerhans. Both of the antibodies labelled the 
105 kDa band in SR prepared from skeletal muscle (Fig. 2, 
lanes A and B). It seems that the molecular mass of the 
SERCA protein in /3-cells and in islet of Langerhans is 
slightly higher than in skeletal muscle. This observation is
in accordance with the previous phosphorylation results in 
indicating that /3-cells contain a 115 kDa SERCA isoform. 
The SERCA-2b antibody labelled a protein of similar 
molecular mass in /3-cel!Js and islets of Langerhans as that 
labelled by the EM-2 and EM-3 antibodies. However, no 
immunoreaction was seen with SR prepared from skeletal 
muscle (Fig. 2, lane C). This antibody was raised against 
the last 12 C-terminal amino acids of the SERCA-2b 
Ca2+-ATPase [24] which is unique for this isoform. In 
accordance with the specificity of the SERCA-2b antibody, 
we did not observe any cross-reactivity with the SERCA-1 
skeletal muscle SR Ca2+-ATPase. Thus the/3-cells contain 
the SERCA-2b isoform. 
The 5FI0 monoclonal antibody, which was raised 
against he human erythlrocyte PMCA, reacted with a 150 
kDa protein in /3-cells, in islets of Langerhans and with the 
140 kDa band in human and rat erythrocytes which were 
used as controls (Fig. 3). The estimated molecular masses 
are slightly higher than those expected from published 
values because of the different gel electrophoresis system 
used. We therefore identify the 150 kDa species as a 
/3-cell PMCA. 
3.3. Specific inhibition of Ca 2 +-pump hosphoenzyme in-
termediate formation by thapsigargin and tBHQ 
To further confirm that the 115 kDa species is a SERCA 
isoform we studied the effects of specific SERCA in- 
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Fig. 3. Immunological detection of plasma membrane Ca2+-ATPase in 
cultured /3-cell ines, islets of Langerhans and in human and rat erythro- 
cytes using monoclonal anti-human erythrocyte plasma membrane Ca2+- 
ATPase antibody (Clone 5FI0). MIN, HIT and RIN B-cells, islets of 
Langerhans (IL), human erythrocyte (HE) and rat erythrocyte (RE) 
membrane preparations were separated by SDS-PAGE on 7.5% acidic 
gels. 100 /xg of membrane proteins were applied to each lane. The gels 
were lectroblotted onto Immobilon membranes and incubated with l:1000 
dilution of 5F10 monoclonal antibody. The bound antibody was detected 
by reaction with alkaline phosphatase-conjugated an i-mouse IgG anti- 
body (1:7500 dilution) as described under Section 2. 
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Fig. 4. Inhibition of the phosphoenzyme intermediate formation of Ca2+-ATPases by thapsigargin. Ca2+-pumps in membrane proteins from MIN/3-cells, 
human erythrocytes (HE) and from sarcoplasmic reticulum (SR) were labelled with [3'-32 P]ATP in the absence or the presence of various concentration of
thapsigargin. 50/xg of MIN and HE membrane proteins and 12.5 ng of SR proteins were used. The phosphorylated proteins were resolved by SDS-PAGE 
and autoradiographed. The concentrations of thapsigargin were: 0 and 5 ~M in SR and HE samples, 0, 0.1, 0.5, 1, 5, 10 and 50 /zM in MIN samples. 
hibitors on the formation of the phosphoenzyme intermedi- 
ate. When the CaZ+-pumps in MIN fl-cell membranes 
were labelled with [3'-32 P]ATP at increasing thapsigargin 
concentrations, the autophosphorylation of the 115 kDa 
CaZ+-pump was inhibited, while no effect was observed on 
phosphorylation f the 150 kDa pump protein. Inhibition 
occurred with 0.5-1.0 /zM thapsigargin and above 1 /zM 
thapsigargin the inhibition was complete (Fig. 4). Skeletal 
muscle SR and human erythrocyte membranes were used 
as controls. The phosphorylation of the 105 kDa SR 
Ca2+-ATPase protein was inhibited in the presence of 5 
/xM thapsigargin, but the same thapsigargin concentration 
in erythrocyte membrane samples did not affect phospho- 
enzyme intermediate formation of the 140 kDa PMCA 
(Fig. 4). 
Phosphorylation f the 115 kDa SERCA protein in MIN 
/3-cell membranes was also inhibited by tBHQ. The inhibi- 
tion was complete at 0.1 mM tBHQ concentration. The 
inhibitor had no effect on PMCA phosphorylation, even at 
a high (10 mM) tBHQ concentration (Fig. 5). 
3.4. Trypsin proteolysis of Ca 2 +-pumps 
As no specific inhibitors of PMCA are available, we 
sought o confirm our identification of the 150 kDa species 
as PMCA by carrying out limited tryptic digestion which 
yields different characteristic cleavage products of PMCA 
and SERCA [33]. Following tryptic cleavage of the Ca 2+- 
pumps in MIN /3-cell membranes, the resulting fragments 
were phosphorylated (Fig. 6A, lanes 1-8). After exposure 
to 100 /zg/ml trypsin for 2 and 5 rain (Fig. 6A, lanes 3 
and 4), two bands appeared with molecular masses of 
about 80 and 55 kDa. The 55 kDa fragment probably arose 
from the 115 kDa SERCA protein as it was also obtained 
after tryptic cleavage of skeletal muscle SR Ca 2 +-ATPase 
as detected either by phosphorylation (Fig. 6A, line 10) or 
by immunoreaction with EM-3 antibody (Fig. 6A, lane 
12). To confirm the origin of the 55 kDa fragment, we also 
tried to use immunolabelling, but the EM-2, EM-3 antibod- 
ies did not show detectable reaction with the tryptic frag- 
ments of SERCA in MIN fl-cell membranes under these 
conditions. The SERCA-2b antibody raised against a C- 
terminal oligopeptide, as expected, did not label the phos- 
phorylated 55 kDa fragment which contains the N-terminal 
half of the enzyme (results not shown). The 80 kDa band 
MIN 
116- SERCA 
94- 
67. 
[ 
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Fig. 5. Inhibition of the phosphoenzyme intermediate formation of Ca 2+- 
ATPases in MIN /3-cells by tBHQ. The membranes were preincubated 
with 5.10 6_10-2 M tBHQ for 5 min at 37°C and then radiolabelled 
with [T-32p]ATP at 4 ° C in medium containing 20 /zM CaCI 2, 50 /xM 
LaC13, 75 mM KC1, 30 mM Hepes (pH 7.0) and 0.5 mg/ml  protein. The 
proteins were separated on 7.5% acidic SDS-polyacrylamide gels and 
autoradiographed. 
A. Vdradi et al. / Biochimica et Biophysica Acta 1236 (1995) 119-127 125 
212 - 
170 - 
116-  
94- 
x 
.~ 67-. 
43.. 
A 
PMCA 
SERCA 
Fig. 6. Tryptic digestion of Ca2+-ATPases in MIN /3-cell, sarcoplasmic reticulum and human erythrocyte membranes. (A) MIN /3-cell (lanes 1-8) and 
sarcoplasmic reticulum (SR) (lanes 9-12) proteins were partially digested with trypsin as described under Section 2. Aliquots were taken before the 
addition of trypsin (lanes 1, 9, 11) and after 2 min (lanes 3, 5, 7) and 5 min (lanes 4, 6, 8, 10, 12). The reaction was terminated bythe addition of 20-fold 
excess of soybean trypsin inhibitor. The proteolysis products were either labelled with [7-32p]ATP (lanes 1-10) or with EM-3 antibody (lanes 11, 12) in 
the presence of 0.5 /zM (lines 5, 6) or 2 /xM (lanes 7, 8) thapsigargin. Lane 2, trypsin and soybean trypsin inhibitor were added simultaneously to the 
sample. (B) Membrane proteins (1 mg/ml) from MIN6/3-cells and human erythrocytes (HE) were partially digested with 100/xg/ml trypsin at 4 ° C for 0 
rain (lanes 1, 4), for 2 rnin (lanes 2, 5) and for 5 min (lanes 3, 6). The products of proteolysis were separated by SDS-PAGE on 7.5% acidic gels, 
transferred to Immobilon membranes, and then incubated with a 1 : 1000 dilution of the 5F10 antibody, as described under Section 2. Each sample contained 
100 /zg of membrane proteins. The bound antibody was detected by reaction with alkaline phosphatase-conjugated an i-mouse IgG antibody at 1:7500 
dilution. 
was recognised by 5F10 antibody (Fig. 6B, lines 2 and 3) 
and is therefore a proteolytic fragment of the PMCA. After 
proteolytic treatment, a band with molecular mass around 
76 kDa was labelled by 5F10 antibody in human erythro- 
cyte membranes, and is therefore a proteolytic fragment of 
PMCA. 
The effects of thapsigargin on tryptic proteolysis are 
also shown in Fig. 6A (limes 5-8).  In contrary to the intact 
enzyme, thapsigargin had no effect on the phosphorylation 
of the 55 kDa tryptic fragment derived from SERCA. In 
the presence of 0.5 or 2 /zM thapsigargin a new 68 kDa 
fragment appeared, which is probably either a different 
proteolytic fragment or a further degradation product of 
the 80 kDa fragment whJLch disappeared under these condi- 
B 
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FIE;. 6 (continued). 
tions. It seems that thapsigargin affects the proteolytic 
cleavage pattern of the PMCA protein, but does not inhibit 
the ability of the tryptic fragments of the SERCA to 
autophosphorylate. 
4. Discussion 
The presence of PMCA in islets of Langerhans has 
previously been inferred from studies of Ca 2+ fluxes. 
Attempts to detect plasma membrane Ca2+-ATPase activ- 
ity have also been reported [25-28,45-47]. However, these 
data suffer from two limitations. Firstly, the presence of 
membrane from other cellular sites in the putative plasma 
membrane fractions used can not be excluded. Secondly, 
we have found (Ashcroft, S.J.H., unpublished observa- 
tions) that although rat islet membrane preparations pos- 
sess a very high Ca2+-dependent ATPase activity, this is 
not attributable to a Ca2+-pumping ATPase since it is as 
active in the presence of Mg 2+ as in the presence of Ca 2+. 
Moreover, this Ca-Mg-ATPase activity is primarily located 
extracellularly since intact islets or /3-cells are also highly 
active in Ca-Mg-dependent ATP hydrolysis and therefore 
this /3-cell ATPase is an ectoenzyme, possibly similar to 
liver ectoATPase [48]. Previous studies on the ATPase 
activity in homogenates of islets of Langerhans have failed 
to take account of the presence of Ca-Mg-ectoATPase in 
their preparations. 
The present study provides clear evidence for the pres- 
ence of PMCA in /3-cells. Under conditions that exclude 
the possibility of protein kinase-catalysed phosphorylation, 
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we demonstrated the formation of a 150 kDa phosphopro- 
tein in /J-cell membranes. The identification of this band 
as a phosphoenzyme intermediate of PMCA was con- 
firmed by the immunolabelling of a band of identical 
mobility using an antibody (5FI0) which cross-reacts with 
the Ca2+-ATPases of other plasma membranes [49] and 
does not distinguish between the different isoforms of 
PMCA. Moreover, in MIN6 /J-cell membranes, upon lim- 
ited trypsin proteolysis, the disappearance of the 150 kDa 
band was accompanied by formation of an 80 kDa au- 
tophosphorylatable Ca2+-pump fragments which also re- 
acted with 5F10 anti-PMCA antibody. 
Although 5F10 antibody labelled a 150 kDa protein in 
/J-cells and in islets of Langerhans, a slightly smaller 140 
kDa band was recognised in erythrocytes. Similar to our 
results, it has been found that the 5F10 antibody labelled a 
145 kDa protein in liver [50,51], which exceeded the 
molecular mass of the erythrocyte PMCA by 5-10 kDa. 
The possibility of different glycosylation or a sequence 
insertion in the pump molecule could account for the 
molecular mass difference, but no conclusive xplanations 
for the difference can be offered currently. The 1 and 4 
isoforms of PMCA are transcribed in most of the tissues 
tested [10,15], with the isoform 1 being the more abun- 
dantly expressed. PCR analysis has shown that the rat 
exocrine pancreas expresses PMCA-I mRNA predomi- 
nantly [52]. Similarly to the liver [50,51] and to the small 
intestine [53], the /J-cells and islets of Langerhans proba- 
bly express the PMCAI isoform. Further studies are re- 
quired to resolve this point. 
There is considerable evidence for a functionally impor- 
tant Ca2+-store in the endoplasmic reticulum of /J-cells 
[54,55]. The presence of a SERCA can be inferred from 
the increase in /J-cell intracellular Ca 2+ elicited by thapsi- 
gargin [30,31,56]. Uptake and release of Ca 2 + from micro- 
somal preparations derived from /J-cells has also been 
documented [54,57,58]. The Ca2+-ATPase activity of /3- 
cell microsomal preparations has been ascribed to the 
activity of SERCA, but in our view these studies suffer 
from the same limitations as those that have sought to 
measure the ATPase activity of PMCA. In one study more 
direct evidence for the presence of SERCA was provided 
by immunolabelling Western blots of islets of Langerhans 
with an anti-SERCA antibody [31]. The present study 
extends this latter observation i several ways. We demon- 
strated that /j-cell membranes, under conditions where 
protein kinases are inactive, incorporate radioactivity from 
[y-32p]ATP into a 115 kDa band. Confirmation that this 
species is the phosphoenzyme intermediate of SERCA 
came from inhibitor studies. Thapsigargin, as well as 
tBHQ, selectively inhibits the enzymes of the SERCA 
family [59-61] and has no effect on the activity of PMCA 
[62]. We showed that phosphorylation of the 115 kDa 
SERCA protein in /J-cell membranes was inhibited in a 
dose-dependent manner by both these inhibitors and no 
effect was observed on phosphorylation of the 150 kDa 
PMCA protein. Immunological studies further supported 
this identity. Thus, anti-SERCA antibodies (EM-2 and 
EM-3) reacted with a species of identical mobility on 
Western blots of /j-cells to that obtained by radiolabelling. 
Using an isoform-specific antibody, we demonstrated that 
the isoform of SERCA present in cultured /j-cells and 
islets of Langerhans i of the SERCA-2b type. In contrast 
to the two Ca2+-ATPase isoforms which were labelled 
(1 11 kDa and 97 kDa) in exocrine pancreatic endoplasmic 
reticulum [24], the SERCA-2b (and also the EM-2 and 
EM-3) antibodies labelled just one 115 kDa band in en- 
docrine pancreatic /J-cells. 
Papp et al. [63] observed that La 3 + abolished the inhibi- 
tion by thapsigargin of the SERCA pumps and phospho- 
rylation of its proteolytic fragments even at 2 /~M thapsi- 
gargin concentration, which gave complete inhibition in 
the absence of La 3 +. However, we found that inhibition of 
the SERCA-2b protein was complete with 1 /~M thapsi- 
gargin in the presence of La 3+. Thapsigargin did not 
inhibit autophosphorylation of any of the trypsinised frag- 
ments in the presence of La3+; however, the tryptic cleav- 
age pattern of PMCA was changed by thapsigargin in a 
dose-dependent manner. The reason for this is unknown, 
but may indicate that thapsigargin is able to interact with 
PMCA without causing functional inhibition. The nature of 
the binding site for thapsigargin has not been established 
[21]. 
In conclusion, our results demonstrate hat two separate 
calcium transport ATPases, SERCA-2b and PMCA (prob- 
ably PMCA1), are present in cultured /J-cells and islets of 
Langerhans. 
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